Tetherex Pharmaceuticals Corp
Oklahoma City, US · Founded 2014 · Delaware corporation · 1 known investors
Founders & leadership
Tetherex Pharmaceuticals Corp was founded in 2014 by Scott Rollins, Ph.D..
SR
Scott Rollins, Ph.D.Founder
DF
David FaclonerExecutive
RA
Richard AlvarezExecutive
RM
Rodger McEver, M.D.Named on SEC filing
RR
Russell RotherNamed on SEC filing
Board
TF
DK
David KeiserBoard director
PJ
Philip Jones, M.D.Board director
Investors · 1
Reported raises · per SEC filings
Form D private placements$48.2M disclosed across 3 of 4 rounds · 2015–2020
▶Undisclosed amountofferedDec 2020 · 1 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedDec 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott Rollins, Ph.D.Executive Officer, Director
- Rodger McEver, M.D.Director
- Richard AlvarezExecutive Officer
- Scott SamaraDirector
- Philip Jones, M.D.Director
- Russell Rother, Ph.D.Executive Officer, Director
- Todd FoleyDirector
- David KeiserDirector
- Jonathan Stocker, Ph.D.Executive Officer
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$43MraisedMar 2018 · 240 investors · BiotechnologyRule 506(b)
▶$43MraisedMar 2018 · 240 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip Jones, M.D.Director
- Rodger McEver, M.D.Director
- Richard AlvarezExecutive Officer
- David KeiserDirector
- David FaclonerExecutive Officer
- Russell Rother, Ph.D.Executive Officer, Director
- Scott Rollins, Ph.D.Executive Officer, Director
- Jonathan Stocker, Ph.D.Executive Officer
- Todd FoleyDirector
- Offering amount
- $50M
- Amount sold
- $43M
- Minimum investment
- $10K
- Proceeds to insiders
- $1.2M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedOct 2015 · 30 investors · BiotechnologyRule 506(b)
▶$4MraisedOct 2015 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip Jones, M.D.Director
- Scott Rollins, Ph.D.Executive Officer, Director
- Todd FoleyDirector
- Richard AlvarezExecutive Officer
- David KeiserDirector
- David FaclonerExecutive Officer
- Russell RotherExecutive Officer
- Rodger McEver, M.D.Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $50K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b, 05
▶$1.3MraisedFeb 2015 · 14 investors · BiotechnologyRule 506(b)
▶$1.3MraisedFeb 2015 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David FaclonerExecutive Officer
- Richard AlvarezExecutive Officer
- Rodger McEver, M.D.Director
- David KeiserDirector
- Scott Rollins, Ph.D.Executive Officer, Director
- Russell RotherExecutive Officer
- Philip Jones, M.D.Director
- Todd FoleyDirector
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- Minimum investment
- $5.3K
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Tetherex Pharmaceuticals Corp?
- Tetherex Pharmaceuticals Corp was founded by Scott Rollins, Ph.D. in 2014.
- Who are Tetherex Pharmaceuticals Corp's investors?
- Tetherex Pharmaceuticals Corp's investors include MPM BioImpact.
- How much funding has Tetherex Pharmaceuticals Corp raised?
- Tetherex Pharmaceuticals Corp has disclosed $48.2M raised across 3 of its 4 known rounds.
- Where is Tetherex Pharmaceuticals Corp headquartered?
- Tetherex Pharmaceuticals Corp is headquartered in Oklahoma City, US.